Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion
oleh: Zhihua Miao, Tianhao Mu, Longying Liu, Jingjie Rao, Min Jin, Zhizheng Wang, Hui Wang, Chao Lu, Xiaolin Gong, Dongcai Zheng, Daoming Zheng, Xin Li, Yingmei Li, Shifu Chen, Xinhua Shu
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2020-10-01 |
Deskripsi
Precision medicine has been getting more attention in lung cancer treatment. Here, we report an unusual case of a 71-year-old Chinese male patient with poorly differentiated lung adenocarcinoma with lymph node metastasis. A 5 years' treatment history of this patient is reported. By serial genetic tests of circulating tumor DNA (ctDNA) from peripheral blood and sediment cell genomic DNA (PE-sDNA) from pleural effusion, a novel chronological combination treatment of icotinib, osimertinib, and crizotinib was adopted for the present genetic mutations, including EGFR exon 19 deletion, EGFR p.T790M, and MET amplification.